首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1418378

胎儿游离 DNA 检测市场报告：2030 年趋势、预测与竞争分析

Cell Free Fetal DNA Testing Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: 2024年01月29日 | 出版商:

Lucintel | 英文 150 - page report | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

胎儿游离 DNA 检测的趋势与预测

预计 2024 年至 2030 年，全球胎儿游离 DNA 检测市场将以 12.3% 的复合年增长率成长。该市场的主要驱动因素是人们对遗传疾病的认识不断提高，以及产科对安全、低风险的产前诊断技术的日益偏好。胎儿游离DNA检测的全球市场前景广阔，在医院和临床中心的应用机会庞大。

胎儿游离 DNA 检测市场洞察

Lucintel 预测，染色体畸变检测预计将在预测期内呈现最高成长，因为它被广泛用于检测各种染色体异常。

由于其发达的医疗保健系统以及与游离 DNA 检测相关的各种疾病的发生频率不断增加，预计北美在预测期内将出现最高的增长。

常问问题

Q1.市场成长预测如何？

A1. 预计 2024 年至 2030 年，全球胎儿游离 DNA 检测市场将以 12.3% 的复合年增长率成长。

Q2.影响市场成长的主要驱动因素有哪些？

A2. 该市场的主要驱动力是人们对遗传疾病的认识不断提高，以及产科对安全、低风险的产前诊断技术的日益偏好。

Q3.市场的主要细分市场有哪些？

A3. 胎儿游离DNA检测市场的前景看好，医院和临床中心市场也充满机会。

Q4.市场上主要企业有哪些？

A4.进行胎儿游离DNA检测的主要企业如下。

The Fetal Medicine Centre
Apollo Path labs
Ariosa Diagnostics
Sequenom Laboratories
Laboratory Corporation of America Holdings
Personal Genome Diagnostics
Premaitha Health
Berry Genomics
Roche Holdings
Trovagene

Q5.未来最大的细分市场是什么？

A5.Lucintel预测异常染色体数目检测将在预测期内呈现最高增长，因为它被广泛用于检测各种染色体异常。

Q6. 未来五年预计哪个地区将成为最大的市场？

A6. 由于其发达的医疗保健系统以及该地区人口中与游离DNA检测相关的各种疾病的发生频率不断增加，北美将在预测期内出现最高的增长。

Q7. 可以客製化报告吗？

A7. 是的，Lucintel 提供 10% 的客製化服务，无需额外费用。

宏观经济趋势（2018-2023）与预测（2024-2030）
胎儿游离DNA检测的全球市场趋势（2018-2023）与预测（2024-2030）
按类型分類的全球胎儿游离 DNA 检测市场
- 染色体数目异常检测
- 性别测试
- 父系遗传疾病检测
- 亲子鑑定
- 其他的
胎儿游离 DNA 检测的全球市场：依应用分类
- 医院
- 诊所中心
- 其他的

第四章 2018-2030年区域市场趋势及预测分析

按地区分類的全球胎儿游离 DNA 检测市场
北美胎儿游离DNA检测市场
欧洲胎儿游离DNA检测市场
亚太胎儿游离DNA检测市场
其他地区胎儿游离DNA检测市场

第五章竞争分析

产品系列分析
营运整合
波特五力分析

第六章成长机会与策略分析

成长机会分析
- 全球胎儿游离 DNA 检测市场成长机会（按类型）
- 全球胎儿游离 DNA 检测市场成长机会（按应用）
- 全球胎儿游离 DNA 检测市场成长机会（按地区）
全球胎儿游离DNA检测市场新趋势
战略分析
- 新产品开发
- 扩大胎儿游离 DNA 检测的全球市场容量
- 全球胎儿游离DNA检测市场的合併、收购与合资
- 认证和许可

第七章主要企业概况

The Fetal Medicine Centre
Apollo Path labs
Ariosa Diagnostics
Sequenom Laboratories
Laboratory Corporation of America Holdings
Personal Genome Diagnostics
Premaitha Health
Berry Genomics
Roche Holdings
Trovagene

简介目录

Cell Free Fetal DNA Testing Trends and Forecast

The future of the global cell free fetal DNA testing market looks promising with opportunities in the hospital and clinic center applications. The global cell free fetal DNA testing market is expected to grow with a CAGR of 12.3% from 2024 to 2030. The major drivers for this market are raising consciousness regarding genetic disorders and growing preference for secure and minimally risky prenatal diagnostic techniques in obstetrics.

A more than 150-page report is developed to help in your business decisions.

Cell Free Fetal DNA Testing by Segment

The study includes a forecast for the global cell free fetal DNA testing by type, application, and region.

Cell Free Fetal DNA Testing Market by Type [Shipment Analysis by Value from 2018 to 2030]:

Abnormal Chromosome Number Detection
Gender Testing
Paternally Inherited Disorder Detection
Paternity Testing
Others

Cell Free Fetal DNA Testing Market by Application [Shipment Analysis by Value from 2018 to 2030]:

Hospital
Clinic Center
Others

Cell Free Fetal DNA Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:

North America
Europe
Asia Pacific
The Rest of the World

List of Cell Free Fetal DNA Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cell free fetal DNA testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cell free fetal DNA testing companies profiled in this report include-

The Fetal Medicine Centre
Apollo Path labs
Ariosa Diagnostics
Sequenom Laboratories
Laboratory Corporation of America Holdings
Personal Genome Diagnostics
Premaitha Health
Berry Genomics
Roche Holdings
Trovagene

Cell Free Fetal DNA Testing Market Insights

Lucintel forecasts that abnormal chromosome number detection is expected to witness highest growth over the forecast period due to its widespread use in detecting variety of chromosomal disorders.

North America is expected to witness highest growth over the forecast period due to existence of developed healthcare system and increasing frequency of various diseases linked to cell-free DNA testing among population of the region.

Features of the Global Cell Free Fetal DNA Testing Market

Market Size Estimates: Cell free fetal DNA testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cell free fetal DNA testing market size by type, application, and region in terms of value ($B).

Regional Analysis: Cell free fetal DNA testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the cell free fetal DNA testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cell free fetal DNA testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for cell free fetal DNA testing market?

Answer: The global cell free fetal DNA testing market is expected to grow with a CAGR of 12.3% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the cell free fetal DNA testing market?

Answer: The major drivers for this market are raising consciousness regarding genetic disorders and growing preference for secure and minimally risky prenatal diagnostic techniques in obstetrics.

Q3. What are the major segments for cell free fetal DNA testing market?

Answer: The future of the cell free fetal DNA testing market looks promising with opportunities in the hospital and clinic center markets.

Q4. Who are the key cell free fetal DNA testing market companies?

Answer: Some of the key cell free fetal DNA testing companies are as follows.

The Fetal Medicine Centre
Apollo Path labs
Ariosa Diagnostics
Sequenom Laboratories
Laboratory Corporation of America Holdings
Personal Genome Diagnostics
Premaitha Health
Berry Genomics
Roche Holdings
Trovagene

Q5. Which cell free fetal DNA testing market segment will be the largest in future?

Answer: Lucintel forecasts that abnormal chromosome number detection is expected to witness highest growth over the forecast period due to its widespread use in detecting variety of chromosomal disorders.

Q6. In cell free fetal DNA testing market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to existence of developed healthcare system and increasing frequency of various diseases linked to cell-free DNA testing among population of the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the cell free fetal DNA testing market by type (abnormal chromosome number detection, gender testing, paternally inherited disorder detection, paternity testing, and others), application (hospital, clinic center, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Global Cell Free Fetal DNA Testing Market : Market Dynamics

2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Cell Free Fetal DNA Testing Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Cell Free Fetal DNA Testing Market by Type
- 3.3.1: Abnormal Chromosome Number Detection
- 3.3.2: Gender Testing
- 3.3.3: Paternally Inherited Disorder Detection
- 3.3.4: Paternity Testing
- 3.3.5: Others
3.4: Global Cell Free Fetal DNA Testing Market by Application
- 3.4.1: Hospital
- 3.4.2: Clinic Center
- 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

4.1: Global Cell Free Fetal DNA Testing Market by Region
4.2: North American Cell Free Fetal DNA Testing Market
- 4.2.2: North American Cell Free Fetal DNA Testing Market by Application: Hospital, Clinic Center, and Others
4.3: European Cell Free Fetal DNA Testing Market
- 4.3.1: European Cell Free Fetal DNA Testing Market by Type: Abnormal Chromosome Number Detection, Gender Testing, Paternally Inherited Disorder Detection, Paternity Testing, and Others
- 4.3.2: European Cell Free Fetal DNA Testing Market by Application: Hospital, Clinic Center, and Others
4.4: APAC Cell Free Fetal DNA Testing Market
- 4.4.1: APAC Cell Free Fetal DNA Testing Market by Type: Abnormal Chromosome Number Detection, Gender Testing, Paternally Inherited Disorder Detection, Paternity Testing, and Others
- 4.4.2: APAC Cell Free Fetal DNA Testing Market by Application: Hospital, Clinic Center, and Others
4.5: ROW Cell Free Fetal DNA Testing Market
- 4.5.1: ROW Cell Free Fetal DNA Testing Market by Type: Abnormal Chromosome Number Detection, Gender Testing, Paternally Inherited Disorder Detection, Paternity Testing, and Others
- 4.5.2: ROW Cell Free Fetal DNA Testing Market by Application: Hospital, Clinic Center, and Others

5. Competitor Analysis

5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

6.1: Growth Opportunity Analysis
- 6.1.1: Growth Opportunities for the Global Cell Free Fetal DNA Testing Market by Type
- 6.1.2: Growth Opportunities for the Global Cell Free Fetal DNA Testing Market by Application
- 6.1.3: Growth Opportunities for the Global Cell Free Fetal DNA Testing Market by Region
6.2: Emerging Trends in the Global Cell Free Fetal DNA Testing Market
6.3: Strategic Analysis
- 6.3.1: New Product Development
- 6.3.2: Capacity Expansion of the Global Cell Free Fetal DNA Testing Market
- 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cell Free Fetal DNA Testing Market
- 6.3.4: Certification and Licensing